img

Global and India Targeted Radionuclide Therapy Market Report & Forecast 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and India Targeted Radionuclide Therapy Market Report & Forecast 2024-2034

Therapeutic Radioligands is a type of targeted cancer therapy that combines the specificity of monoclonal antibodies with the destructive power of radiation. The treatment involves attaching radioactive isotopes to monoclonal antibodies, which are specialized proteins that can recognize and bind to specific antigens found on the surface of cancer cells.
The global Targeted Radionuclide Therapy revenue was US$ 1043 million in 2022 and is forecast to a readjusted size of US$ 4471.9 million by 2029 with a CAGR of 17.4% during the review period (2024-2034).
In India, the Targeted Radionuclide Therapy revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period 2024-2034.
The key drivers of the radioimmunotherapy market is its potential to deliver highly targeted and precise treatment to cancer cells, sparing healthy tissues and reducing side effects compared to traditional radiation therapies. The ability of RIT to offer personalized treatment options based on specific cancer biomarkers further enhances its appeal in the field of precision medicine. However, the radioimmunotherapy market also faces challenges. One major challenge is the high cost associated with the development and production of radiopharmaceuticals, limiting access for some patients and healthcare systems. Additionally, navigating complex regulatory pathways for approval and reimbursement of RIT products can be time-consuming and resource-intensive for pharmaceutical companies. Furthermore, there may be limited awareness and acceptance of RIT among healthcare professionals and patients, leading to slower adoption rates and market penetration. Addressing these challenges requires continued research and investment in RIT technologies to improve efficacy and cost-effectiveness. Collaborations between pharmaceutical companies, research institutions, and healthcare organizations can facilitate knowledge-sharing and streamline the regulatory process.
This report focuses on global and India Targeted Radionuclide Therapy market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2024, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Targeted Radionuclide Therapy will continue to grow rapidly in the future.
Global Targeted Radionuclide Therapy Scope and Market Size
Targeted Radionuclide Therapy market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Targeted Radionuclide Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2029.
For India market, this report focuses on the Targeted Radionuclide Therapy market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.



By Company


Bayer
Novartis
Lantheus
Aurobindo Pharma
Mundipharma
China Isotope & Radiation
Curium Pharmaceuticals
Gilead Sciences
Clarity Pharmaceuticals
Curasight
Nordic Nanovector
Philogen
RadioMedix
Telix Pharmaceuticals
Orano Med
Actinium Pharmaceuticals
Y-mAbs Therapeutics
Fusion Pharmaceuticals
Segment by Type
Beta-emitting
Targeted Alpha Therapy

Segment by Application


Solid Tumor
Non Hodgkin Lymphoma
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Targeted Radionuclide Therapy definition, global market size, India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Targeted Radionuclide Therapy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Targeted Radionuclide Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Targeted Radionuclide Therapy revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions

Table of Content

1 Study Coverage
1.1 Targeted Radionuclide Therapy Product Introduction
1.2 Global Targeted Radionuclide Therapy Outlook 2018 VS 2022 VS 2029
1.2.1 Global Targeted Radionuclide Therapy Market Size for the Year 2018-2029
1.2.2 India Targeted Radionuclide Therapy Market Size for the Year 2018-2029
1.3 Targeted Radionuclide Therapy Market Size, India VS Global, 2018 VS 2022 VS 2029
1.3.1 The Market Share of India Targeted Radionuclide Therapy in Global, 2018 VS 2022 VS 2029
1.3.2 The Growth Rate of Targeted Radionuclide Therapy Market Size, India VS Global, 2018 VS 2022 VS 2029
1.4 Targeted Radionuclide Therapy Market Dynamics
1.4.1 Targeted Radionuclide Therapy Industry Trends
1.4.2 Targeted Radionuclide Therapy Market Drivers
1.4.3 Targeted Radionuclide Therapy Market Challenges
1.4.4 Targeted Radionuclide Therapy Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Targeted Radionuclide Therapy by Type
2.1 Targeted Radionuclide Therapy Market Segment by Type
2.1.1 Beta-emitting
2.1.2 Targeted Alpha Therapy
2.2 Global Targeted Radionuclide Therapy Market Size by Type (2018, 2022 & 2029)
2.3 Global Targeted Radionuclide Therapy Market Size by Type (2018-2029)
2.4 India Targeted Radionuclide Therapy Market Size by Type (2018, 2022 & 2029)
2.5 India Targeted Radionuclide Therapy Market Size by Type (2018-2029)
3 Targeted Radionuclide Therapy by Application
3.1 Targeted Radionuclide Therapy Market Segment by Application
3.1.1 Solid Tumor
3.1.2 Non Hodgkin Lymphoma
3.2 Global Targeted Radionuclide Therapy Market Size by Application (2018, 2022 & 2029)
3.3 Global Targeted Radionuclide Therapy Market Size by Application (2018-2029)
3.4 India Targeted Radionuclide Therapy Market Size by Application (2018, 2022 & 2029)
3.5 India Targeted Radionuclide Therapy Market Size by Application (2018-2029)
4 Global Targeted Radionuclide Therapy Competitor Landscape by Company
4.1 Global Targeted Radionuclide Therapy Market Size by Company
4.1.1 Global Key Companies of Targeted Radionuclide Therapy, Ranked by Revenue (2022)
4.1.2 Global Targeted Radionuclide Therapy Revenue by Player (2018-2024)
4.2 Global Targeted Radionuclide Therapy Concentration Ratio (CR)
4.2.1 Targeted Radionuclide Therapy Market Concentration Ratio (CR) (2018-2024)
4.2.2 Global Top 5 and Top 10 Largest Companies of Targeted Radionuclide Therapy in 2022
4.2.3 Global Targeted Radionuclide Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Targeted Radionuclide Therapy Head office and Area Served
4.4 Global Key Players of Targeted Radionuclide Therapy, Product and Application
4.5 Global Key Players of Targeted Radionuclide Therapy, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 India Targeted Radionuclide Therapy Market Size by Company
4.7.1 Key Players of Targeted Radionuclide Therapy in India, Ranked by Revenue (2022)
4.7.2 India Targeted Radionuclide Therapy Revenue by Players (2021, 2022 & 2024)
5 Global Targeted Radionuclide Therapy Market Size by Region
5.1 Global Targeted Radionuclide Therapy Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Targeted Radionuclide Therapy Market Size by Region (2018-2029)
5.2.1 Global Targeted Radionuclide Therapy Market Size by Region: 2018-2024
5.2.2 Global Targeted Radionuclide Therapy Market Size by Region (2024-2029)
6 Americas
6.1 Americas Targeted Radionuclide Therapy Market Size YoY Growth 2018-2029
6.2 Americas Targeted Radionuclide Therapy Market Size by Type
6.2.1 Americas Targeted Radionuclide Therapy Market Size by Type (2018-2024)
6.2.2 Americas Targeted Radionuclide Therapy Market Size by Type (2024-2029)
6.2.3 Americas Targeted Radionuclide Therapy Market Share by Type (2018-2029)
6.3 Americas Targeted Radionuclide Therapy Market Size by Application
6.3.1 Americas Targeted Radionuclide Therapy Market Size by Application (2018-2024)
6.3.2 Americas Targeted Radionuclide Therapy Market Size by Application (2024-2029)
6.3.3 Americas Targeted Radionuclide Therapy Market Share by Application (2018-2029)
6.4 Americas Targeted Radionuclide Therapy Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Targeted Radionuclide Therapy Market Size YoY Growth 2018-2029
7.2 EMEA Targeted Radionuclide Therapy Market Size by Type
7.2.1 EMEA Targeted Radionuclide Therapy Market Size by Type (2018-2024)
7.2.2 EMEA Targeted Radionuclide Therapy Market Size by Type (2024-2029)
7.2.3 EMEA Targeted Radionuclide Therapy Market Share by Type (2018-2029)
7.3 EMEA Targeted Radionuclide Therapy Market Size by Application
7.3.1 EMEA Targeted Radionuclide Therapy Market Size by Application (2018-2024)
7.3.2 EMEA Targeted Radionuclide Therapy Market Size by Application (2024-2029)
7.3.3 EMEA Targeted Radionuclide Therapy Market Share by Application (2018-2029)
7.4 EMEA Targeted Radionuclide Therapy Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Targeted Radionuclide Therapy Market Size YoY Growth 2018-2029
8.2 China Targeted Radionuclide Therapy Market Size by Type
8.2.1 China Targeted Radionuclide Therapy Market Size by Type (2018-2024)
8.2.2 China Targeted Radionuclide Therapy Market Size by Type (2024-2029)
8.2.3 China Targeted Radionuclide Therapy Market Share by Type (2018-2029)
8.3 China Targeted Radionuclide Therapy Market Size by Application
8.3.1 China Targeted Radionuclide Therapy Market Size by Application (2018-2024)
8.3.2 China Targeted Radionuclide Therapy Market Size by Application (2024-2029)
8.3.3 China Targeted Radionuclide Therapy Market Share by Application (2018-2029)
9 APAC (excluding China)
9.1 APAC Targeted Radionuclide Therapy Market Size YoY Growth 2018-2029
9.2 APAC Targeted Radionuclide Therapy Market Size by Type
9.2.1 APAC Targeted Radionuclide Therapy Market Size by Type (2018-2024)
9.2.2 APAC Targeted Radionuclide Therapy Market Size by Type (2024-2029)
9.2.3 APAC Targeted Radionuclide Therapy Market Share by Type (2018-2029)
9.3 APAC Targeted Radionuclide Therapy Market Size by Application
9.3.1 APAC Targeted Radionuclide Therapy Market Size by Application (2018-2024)
9.3.2 APAC Targeted Radionuclide Therapy Market Size by Application (2024-2029)
9.3.3 APAC Targeted Radionuclide Therapy Market Share by Application (2018-2029)
9.4 APAC Targeted Radionuclide Therapy Market Facts & Figures by Country (2018, 2022 & 2029)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Bayer
10.1.1 Bayer Company Details
10.1.2 Bayer Business Overview
10.1.3 Bayer Targeted Radionuclide Therapy Introduction
10.1.4 Bayer Revenue in Targeted Radionuclide Therapy Business (2018-2024)
10.1.5 Bayer Recent Development
10.2 Novartis
10.2.1 Novartis Company Details
10.2.2 Novartis Business Overview
10.2.3 Novartis Targeted Radionuclide Therapy Introduction
10.2.4 Novartis Revenue in Targeted Radionuclide Therapy Business (2018-2024)
10.2.5 Novartis Recent Development
10.3 Lantheus
10.3.1 Lantheus Company Details
10.3.2 Lantheus Business Overview
10.3.3 Lantheus Targeted Radionuclide Therapy Introduction
10.3.4 Lantheus Revenue in Targeted Radionuclide Therapy Business (2018-2024)
10.3.5 Lantheus Recent Development
10.4 Aurobindo Pharma
10.4.1 Aurobindo Pharma Company Details
10.4.2 Aurobindo Pharma Business Overview
10.4.3 Aurobindo Pharma Targeted Radionuclide Therapy Introduction
10.4.4 Aurobindo Pharma Revenue in Targeted Radionuclide Therapy Business (2018-2024)
10.4.5 Aurobindo Pharma Recent Development
10.5 Mundipharma
10.5.1 Mundipharma Company Details
10.5.2 Mundipharma Business Overview
10.5.3 Mundipharma Targeted Radionuclide Therapy Introduction
10.5.4 Mundipharma Revenue in Targeted Radionuclide Therapy Business (2018-2024)
10.5.5 Mundipharma Recent Development
10.6 China Isotope & Radiation
10.6.1 China Isotope & Radiation Company Details
10.6.2 China Isotope & Radiation Business Overview
10.6.3 China Isotope & Radiation Targeted Radionuclide Therapy Introduction
10.6.4 China Isotope & Radiation Revenue in Targeted Radionuclide Therapy Business (2018-2024)
10.6.5 China Isotope & Radiation Recent Development
10.7 Curium Pharmaceuticals
10.7.1 Curium Pharmaceuticals Company Details
10.7.2 Curium Pharmaceuticals Business Overview
10.7.3 Curium Pharmaceuticals Targeted Radionuclide Therapy Introduction
10.7.4 Curium Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2018-2024)
10.7.5 Curium Pharmaceuticals Recent Development
10.8 Gilead Sciences
10.8.1 Gilead Sciences Company Details
10.8.2 Gilead Sciences Business Overview
10.8.3 Gilead Sciences Targeted Radionuclide Therapy Introduction
10.8.4 Gilead Sciences Revenue in Targeted Radionuclide Therapy Business (2018-2024)
10.8.5 Gilead Sciences Recent Development
10.9 Clarity Pharmaceuticals
10.9.1 Clarity Pharmaceuticals Company Details
10.9.2 Clarity Pharmaceuticals Business Overview
10.9.3 Clarity Pharmaceuticals Targeted Radionuclide Therapy Introduction
10.9.4 Clarity Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2018-2024)
10.9.5 Clarity Pharmaceuticals Recent Development
10.10 Curasight
10.10.1 Curasight Company Details
10.10.2 Curasight Business Overview
10.10.3 Curasight Targeted Radionuclide Therapy Introduction
10.10.4 Curasight Revenue in Targeted Radionuclide Therapy Business (2018-2024)
10.10.5 Curasight Recent Development
10.11 Nordic Nanovector
10.11.1 Nordic Nanovector Company Details
10.11.2 Nordic Nanovector Business Overview
10.11.3 Nordic Nanovector Targeted Radionuclide Therapy Introduction
10.11.4 Nordic Nanovector Revenue in Targeted Radionuclide Therapy Business (2018-2024)
10.11.5 Nordic Nanovector Recent Development
10.12 Philogen
10.12.1 Philogen Company Details
10.12.2 Philogen Business Overview
10.12.3 Philogen Targeted Radionuclide Therapy Introduction
10.12.4 Philogen Revenue in Targeted Radionuclide Therapy Business (2018-2024)
10.12.5 Philogen Recent Development
10.13 RadioMedix
10.13.1 RadioMedix Company Details
10.13.2 RadioMedix Business Overview
10.13.3 RadioMedix Targeted Radionuclide Therapy Introduction
10.13.4 RadioMedix Revenue in Targeted Radionuclide Therapy Business (2018-2024)
10.13.5 RadioMedix Recent Development
10.14 Telix Pharmaceuticals
10.14.1 Telix Pharmaceuticals Company Details
10.14.2 Telix Pharmaceuticals Business Overview
10.14.3 Telix Pharmaceuticals Targeted Radionuclide Therapy Introduction
10.14.4 Telix Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2018-2024)
10.14.5 Telix Pharmaceuticals Recent Development
10.15 Orano Med
10.15.1 Orano Med Company Details
10.15.2 Orano Med Business Overview
10.15.3 Orano Med Targeted Radionuclide Therapy Introduction
10.15.4 Orano Med Revenue in Targeted Radionuclide Therapy Business (2018-2024)
10.15.5 Orano Med Recent Development
10.16 Actinium Pharmaceuticals
10.16.1 Actinium Pharmaceuticals Company Details
10.16.2 Actinium Pharmaceuticals Business Overview
10.16.3 Actinium Pharmaceuticals Targeted Radionuclide Therapy Introduction
10.16.4 Actinium Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2018-2024)
10.16.5 Actinium Pharmaceuticals Recent Development
10.17 Y-mAbs Therapeutics
10.17.1 Y-mAbs Therapeutics Company Details
10.17.2 Y-mAbs Therapeutics Business Overview
10.17.3 Y-mAbs Therapeutics Targeted Radionuclide Therapy Introduction
10.17.4 Y-mAbs Therapeutics Revenue in Targeted Radionuclide Therapy Business (2018-2024)
10.17.5 Y-mAbs Therapeutics Recent Development
10.18 Fusion Pharmaceuticals
10.18.1 Fusion Pharmaceuticals Company Details
10.18.2 Fusion Pharmaceuticals Business Overview
10.18.3 Fusion Pharmaceuticals Targeted Radionuclide Therapy Introduction
10.18.4 Fusion Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2018-2024)
10.18.5 Fusion Pharmaceuticals Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Targeted Radionuclide Therapy Market Size India VS Global, CAGR (2018 VS 2022 VS 2029)
Table 2. Targeted Radionuclide Therapy Market Trends
Table 3. Targeted Radionuclide Therapy Market Drivers
Table 4. Targeted Radionuclide Therapy Market Challenges
Table 5. Targeted Radionuclide Therapy Market Restraints
Table 6. Global Targeted Radionuclide Therapy Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. India Targeted Radionuclide Therapy Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Targeted Radionuclide Therapy Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. India Targeted Radionuclide Therapy Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 10. Global Key Companies of Targeted Radionuclide Therapy, Ranked by Revenue (2022) & (US$ Million)
Table 11. Global Targeted Radionuclide Therapy Revenue by Player, (US$ Million), 2018-2024
Table 12. Global Targeted Radionuclide Therapy Revenue Share by Player, 2018-2024
Table 13. Global Targeted Radionuclide Therapy Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Targeted Radionuclide Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Radionuclide Therapy as of 2022)
Table 15. Global Key Players of Targeted Radionuclide Therapy, Headquarters and Area Served
Table 16. Global Key Players of Targeted Radionuclide Therapy, Product and Application
Table 17. Global Key Players of Targeted Radionuclide Therapy, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Targeted Radionuclide Therapy in India, Ranked by Revenue (2022) & (US$ Million)
Table 20. India Targeted Radionuclide Therapy Revenue by Players, (US$ Million), 2021, 2022 & 2024
Table 21. India Targeted Radionuclide Therapy Revenue Share by Players, 2021, 2022 & 2024
Table 22. Global Targeted Radionuclide Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 23. Global Targeted Radionuclide Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 24. Global Targeted Radionuclide Therapy Market Size Forecast by Region (2024-2029) & (US$ Million)
Table 25. Americas Targeted Radionuclide Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 26. Americas Targeted Radionuclide Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 27. Americas Targeted Radionuclide Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 28. Americas Targeted Radionuclide Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 29. Americas Targeted Radionuclide Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 30. Americas Targeted Radionuclide Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 31. Americas Targeted Radionuclide Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 32. EMEA Targeted Radionuclide Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 33. EMEA Targeted Radionuclide Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 34. EMEA Targeted Radionuclide Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 35. EMEA Targeted Radionuclide Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 36. EMEA Targeted Radionuclide Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. EMEA Targeted Radionuclide Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 38. EMEA Targeted Radionuclide Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 39. China Targeted Radionuclide Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 40. China Targeted Radionuclide Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 41. China Targeted Radionuclide Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 42. China Targeted Radionuclide Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 43. China Targeted Radionuclide Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. APAC Targeted Radionuclide Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 45. APAC Targeted Radionuclide Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 46. APAC Targeted Radionuclide Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 47. APAC Targeted Radionuclide Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 48. APAC Targeted Radionuclide Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 49. APAC Targeted Radionuclide Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 50. APAC Targeted Radionuclide Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 51. Bayer Company Details
Table 52. Bayer Business Overview
Table 53. Bayer Targeted Radionuclide Therapy Product
Table 54. Bayer Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 55. Bayer Recent Development
Table 56. Novartis Company Details
Table 57. Novartis Business Overview
Table 58. Novartis Targeted Radionuclide Therapy Product
Table 59. Novartis Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 60. Novartis Recent Development
Table 61. Lantheus Company Details
Table 62. Lantheus Business Overview
Table 63. Lantheus Targeted Radionuclide Therapy Product
Table 64. Lantheus Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 65. Lantheus Recent Development
Table 66. Aurobindo Pharma Company Details
Table 67. Aurobindo Pharma Business Overview
Table 68. Aurobindo Pharma Targeted Radionuclide Therapy Product
Table 69. Aurobindo Pharma Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 70. Aurobindo Pharma Recent Development
Table 71. Mundipharma Company Details
Table 72. Mundipharma Business Overview
Table 73. Mundipharma Targeted Radionuclide Therapy Product
Table 74. Mundipharma Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 75. Mundipharma Recent Development
Table 76. China Isotope & Radiation Company Details
Table 77. China Isotope & Radiation Business Overview
Table 78. China Isotope & Radiation Targeted Radionuclide Therapy Product
Table 79. China Isotope & Radiation Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 80. China Isotope & Radiation Recent Development
Table 81. Curium Pharmaceuticals Company Details
Table 82. Curium Pharmaceuticals Business Overview
Table 83. Curium Pharmaceuticals Targeted Radionuclide Therapy Product
Table 84. Curium Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 85. Curium Pharmaceuticals Recent Development
Table 86. Gilead Sciences Company Details
Table 87. Gilead Sciences Business Overview
Table 88. Gilead Sciences Targeted Radionuclide Therapy Product
Table 89. Gilead Sciences Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 90. Gilead Sciences Recent Development
Table 91. Clarity Pharmaceuticals Company Details
Table 92. Clarity Pharmaceuticals Business Overview
Table 93. Clarity Pharmaceuticals Targeted Radionuclide Therapy Product
Table 94. Clarity Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 95. Clarity Pharmaceuticals Recent Development
Table 96. Curasight Company Details
Table 97. Curasight Business Overview
Table 98. Curasight Targeted Radionuclide Therapy Product
Table 99. Curasight Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 100. Curasight Recent Development
Table 101. Nordic Nanovector Company Details
Table 102. Nordic Nanovector Business Overview
Table 103. Nordic Nanovector Targeted Radionuclide Therapy Product
Table 104. Nordic Nanovector Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 105. Nordic Nanovector Recent Development
Table 106. Philogen Company Details
Table 107. Philogen Business Overview
Table 108. Philogen Targeted Radionuclide Therapy Product
Table 109. Philogen Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 110. Philogen Recent Development
Table 111. RadioMedix Company Details
Table 112. RadioMedix Business Overview
Table 113. RadioMedix Targeted Radionuclide Therapy Product
Table 114. RadioMedix Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 115. RadioMedix Recent Development
Table 116. Telix Pharmaceuticals Company Details
Table 117. Telix Pharmaceuticals Business Overview
Table 118. Telix Pharmaceuticals Targeted Radionuclide Therapy Product
Table 119. Telix Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 120. Telix Pharmaceuticals Recent Development
Table 121. Orano Med Company Details
Table 122. Orano Med Business Overview
Table 123. Orano Med Targeted Radionuclide Therapy Product
Table 124. Orano Med Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 125. Orano Med Recent Development
Table 126. Actinium Pharmaceuticals Company Details
Table 127. Actinium Pharmaceuticals Business Overview
Table 128. Actinium Pharmaceuticals Targeted Radionuclide Therapy Product
Table 129. Actinium Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 130. Actinium Pharmaceuticals Recent Development
Table 131. Y-mAbs Therapeutics Company Details
Table 132. Y-mAbs Therapeutics Business Overview
Table 133. Y-mAbs Therapeutics Targeted Radionuclide Therapy Product
Table 134. Y-mAbs Therapeutics Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 135. Y-mAbs Therapeutics Recent Development
Table 136. Fusion Pharmaceuticals Company Details
Table 137. Fusion Pharmaceuticals Business Overview
Table 138. Fusion Pharmaceuticals Targeted Radionuclide Therapy Product
Table 139. Fusion Pharmaceuticals Revenue in Targeted Radionuclide Therapy Business (2018-2024) & (US$ Million)
Table 140. Fusion Pharmaceuticals Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Targeted Radionuclide Therapy Product Picture
Figure 2. Global Targeted Radionuclide Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Targeted Radionuclide Therapy Market Size 2018-2029 (US$ Million)
Figure 4. India Targeted Radionuclide Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 5. India Targeted Radionuclide Therapy Market Size 2018-2029 (US$ Million)
Figure 6. India Targeted Radionuclide Therapy Market Share in Global 2018-2029
Figure 7. Targeted Radionuclide Therapy Report Years Considered
Figure 8. Product Picture of Beta-emitting
Figure 9. Product Picture of Targeted Alpha Therapy
Figure 10. Global Targeted Radionuclide Therapy Market Share by Type in 2022 & 2029
Figure 11. Global Targeted Radionuclide Therapy Market Size by Type (2018-2029) & (US$ Million)
Figure 12. Global Targeted Radionuclide Therapy Market Share by Type (2018-2029)
Figure 13. India Targeted Radionuclide Therapy Market Share by Type in 2022 & 2029
Figure 14. India Targeted Radionuclide Therapy Market Size by Type (2018-2029) & (US$ Million)
Figure 15. India Targeted Radionuclide Therapy Market Share by Type (2018-2029)
Figure 16. Product Picture of Solid Tumor
Figure 17. Product Picture of Non Hodgkin Lymphoma
Figure 18. Global Targeted Radionuclide Therapy Market Share by Application in 2022 & 2029
Figure 19. Global Targeted Radionuclide Therapy Market Size by Application (2018-2029) & (US$ Million)
Figure 20. Global Targeted Radionuclide Therapy Market Share by Application (2018-2029)
Figure 21. India Targeted Radionuclide Therapy Market Share by Application in 2022 & 2029
Figure 22. India Targeted Radionuclide Therapy Market Size by Application (2018-2029) & (US$ Million)
Figure 23. India Targeted Radionuclide Therapy Market Share by Application (2018-2029)
Figure 24. The Top 5 and 10 Largest Companies of Targeted Radionuclide Therapy in the World: Market Share by Targeted Radionuclide Therapy Revenue in 2022
Figure 25. Global Targeted Radionuclide Therapy Market Size Market Share by Region: 2018 VS 2022 VS 2029
Figure 26. Global Targeted Radionuclide Therapy Market Share by Region (2018-2029)
Figure 27. Americas Targeted Radionuclide Therapy Market Size Growth Rate 2018-2029 (US$ Million)
Figure 28. Americas Targeted Radionuclide Therapy Market Share by Type (2018-2029)
Figure 29. Americas Targeted Radionuclide Therapy Market Share by Application (2018-2029)
Figure 30. United States Targeted Radionuclide Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 31. Canada Targeted Radionuclide Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 32. Mexico Targeted Radionuclide Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 33. Brazil Targeted Radionuclide Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 34. EMEA Targeted Radionuclide Therapy Market Size Growth Rate 2018-2029 (US$ Million)
Figure 35. EMEA Targeted Radionuclide Therapy Market Share by Type (2018-2029)
Figure 36. EMEA Targeted Radionuclide Therapy Market Share by Application (2018-2029)
Figure 37. Europe Targeted Radionuclide Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 38. Middle East Targeted Radionuclide Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 39. Africa Targeted Radionuclide Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Targeted Radionuclide Therapy Market Size Growth Rate 2018-2029 (US$ Million)
Figure 41. China Targeted Radionuclide Therapy Market Share by Type (2018-2029)
Figure 42. China Targeted Radionuclide Therapy Market Share by Application (2018-2029)
Figure 43. APAC Targeted Radionuclide Therapy Market Size Growth Rate 2018-2029 (US$ Million)
Figure 44. APAC Targeted Radionuclide Therapy Market Share by Type (2018-2029)
Figure 45. APAC Targeted Radionuclide Therapy Market Share by Application (2018-2029)
Figure 46. Japan Targeted Radionuclide Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 47. South Korea Targeted Radionuclide Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 48. China Taiwan Targeted Radionuclide Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 49. Southeast Asia Targeted Radionuclide Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 50. India Targeted Radionuclide Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 51. Bayer Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 52. Novartis Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 53. Lantheus Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 54. Aurobindo Pharma Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 55. Mundipharma Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 56. China Isotope & Radiation Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 57. Curium Pharmaceuticals Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 58. Gilead Sciences Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 59. Clarity Pharmaceuticals Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 60. Curasight Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 61. Nordic Nanovector Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 62. Philogen Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 63. RadioMedix Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 64. Telix Pharmaceuticals Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 65. Orano Med Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 66. Actinium Pharmaceuticals Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 67. Y-mAbs Therapeutics Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 68. Fusion Pharmaceuticals Revenue Growth Rate in Targeted Radionuclide Therapy Business (2018-2024)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries